Roche vs TCS: Founders, CEOs and History
Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker. TCS was founded in 1968 by J.R.D. Tata, F.C. Kohli and is led by K Krithivasan.
Company facts
Founders
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
TCS
J.R.D. Tata
J.R.D. Tata was chairman of Tata Sons from 1938 to 1991. Under his leadership the group set up Tata Computer Centre in 1968, which became Tata Consultancy Services, initially to provide data-processing and management-consultancy services to Tata companies.
F.C. Kohli
Faqir Chand Kohli (1924-2020) moved from Tata Electric Companies to lead TCS in 1969 and served as its first general manager and later CEO until 1996.
CEOs and their tenures
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
TCS
- F. C. Kohli1969–1996
Co-founder and First CEO
By the time Kohli stepped down from executive responsibility in 1996, TCS-trained programmers numbered in the hundreds of thousands and had helped launch India's broader IT-export industry, earning Kohli the title 'Father of the Indian IT Industry' and India's…
Source - N. Chandrasekaran2009–2017
CEO
He became chairman of Tata Sons in February 2017 and also chairs TCS's board and Air India.
Source - Rajesh Gopinathan2017–2023
CEO and Managing Director
Under Gopinathan, TCS shares nearly tripled, revenue almost doubled, and profit rose about 60% over his six-year tenure -- one of the strongest CEO track records in Indian corporate history.
Source - K. Krithivasan2023–present
CEO and Managing Director
Under Krithivasan, TCS crossed $30 billion in annual revenue in FY2026 and grew its annualized AI revenue run rate to $2.6 billion by Q1 FY2027, even as dollar revenue was roughly flat amid weak discretionary IT spending.
Source
Timeline: Roche and TCS side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1968TCS
TCS is founded
Tata Consultancy Services begins inside the Tata Group.
1969TCS
F.C. Kohli Joins as First CEO
F.C. Kohli is brought in on deputation to lead TCS, then a 10-consultant operation, and begins building an industrial, assembly-line approach to software delivery.
2001TCS
CMC Limited Stake Acquired
TCS acquires a majority stake in CMC Limited from the Government of India, adding systems-integration and public-sector technology capability.
2001TCS
TCS Crosses $1 Billion in Revenue
TCS becomes the first Indian IT services company to cross $1 billion in annual revenue, cementing its position as an industry leader.
2004TCS
TCS lists publicly
TCS completes its IPO and becomes one of India's most important listed technology companies.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2009TCS
TCS crosses major global scale thresholds
TCS expands globally across industries and delivery centers under new then-CEO N. Chandrasekaran.
2013TCS
N. Chandrasekaran Becomes CEO
Chandrasekaran becomes CEO, leading TCS through a period of rapid international expansion before his 2017 elevation to Tata Sons chairman.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2020TCS
F.C. Kohli Passes Away
F.C. Kohli, TCS co-founder and first CEO, dies at age 96, having lived to see the company he helped build become one of the worlds largest IT services firms.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2023TCS
K. Krithivasan becomes CEO
K. Krithivasan becomes CEO and managing director of TCS, succeeding Rajesh Gopinathan.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026TCS
FY2026 revenue is reported
TCS reports FY2026 revenue of $30.017B and net margin of 19.8%.
2026TCS
Q1 FY2027 AI run-rate grows
TCS reports Q1 FY2027 revenue of $7.624B and annualized AI revenue of $2.6B.
2026TCS
Tata Sons chairman succession opens
On August 12, 2026, N. Chandrasekaran said he would not seek another term as Tata Sons chairman after February 2027; TCS shares fell about 4% on the news.
Acquisitions
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
TCS
- W12 Studios2018Undisclosed
- Citigroup Global Services2008$505M
- CMC Limited2001Undisclosed
Questions about Roche vs TCS
Who is the CEO of F. Hoffmann-La Roche AG and Tata Consultancy Services Limited?
F. Hoffmann-La Roche AG is led by Thomas Schinecker and Tata Consultancy Services Limited is led by K Krithivasan. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was F. Hoffmann-La Roche AG founded vs Tata Consultancy Services Limited?
F. Hoffmann-La Roche AG was founded in 1896 — 72 years before Tata Consultancy Services Limited, which was founded in 1968. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Tata Consultancy Services Limited.
How many employees does F. Hoffmann-La Roche AG have compared to Tata Consultancy Services Limited?
F. Hoffmann-La Roche AG employs approximately 112,774 people, while Tata Consultancy Services Limited employs approximately 593,798. Tata Consultancy Services Limited has the larger workforce at 593,798 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are F. Hoffmann-La Roche AG and Tata Consultancy Services Limited headquartered?
F. Hoffmann-La Roche AG is headquartered in Switzerland and Tata Consultancy Services Limited is headquartered in India. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded F. Hoffmann-La Roche AG and Tata Consultancy Services Limited?
F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche. Tata Consultancy Services Limited was founded by J.R.D. Tata, F.C. Kohli.
Which company has a longer operating history — F. Hoffmann-La Roche AG or Tata Consultancy Services Limited?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Tata Consultancy Services Limited has been in operation for around 58 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Roche vs TCS overview